icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Boston MA
November 2019
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Oral TLR8 Agonist Selgantolimod in Virally Suppressed Adult Patients With Chronic Hepatitis B: a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
 
 
  AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
 
Edward Gane,1 Yang Zhao,2 Susanna K. Tan,2 Audrey H. Lau,2 Anuj Gaggar,2 Mani Subramanian,2 Jeffrey Wallin,2 Anna E. Brooks,3 P. Rod Dubar,3 Shyam Kottilil,4 Lydia Tang4 1Auckland City Hospital, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, CA; 3The University of Auckland, Auckland, New Zealand; 4University of Maryland School of Medicine, Baltimore, MD

1212191

1212192

1212193

1212194

1212195

1212196

1212197